Manahan Michele A, Goldberg Nelson H, Silverman Ronald P
University of Maryland, Baltimore, MD 21201, USA.
Ann Plast Surg. 2006 Oct;57(4):435-9. doi: 10.1097/01.sap.0000221545.83524.46.
Implantable ventricular-assist devices (VADs) have been approved for use both as a bridge to heart transplantation and as a destination therapy. Rising numbers of patients are surviving with these devices for several years. However, infections of these foreign bodies are serious and frequent complications, often requiring removal of the implant, with serious health consequences. Given the increased use of VADs as life-preserving destination therapy, explantation of these devices in the face of infection is impractical. We evaluated and successfully treated 2 patients with VAD pocket infections referred by the cardiac surgery service at our institution using aggressive surgical and pharmacologic therapy, with the goal of preserving the VADs. However, this is still a largely unsolved dilemma requiring further exploration into prevention and treatment since these devastating infections will likely become a more frequent reconstructive challenge.
植入式心室辅助装置(VADs)已被批准用于心脏移植的过渡治疗以及终末期治疗。越来越多的患者依靠这些装置存活数年。然而,这些异物感染是严重且常见的并发症,常常需要移除植入物,会带来严重的健康后果。鉴于VADs作为挽救生命的终末期治疗的使用增加,在感染情况下移除这些装置是不切实际的。我们对本院心脏外科转诊的2例VAD囊袋感染患者进行了评估,并采用积极的手术和药物治疗成功治愈,目的是保留VADs。然而,这仍然是一个很大程度上未解决的难题,需要进一步探索预防和治疗方法,因为这些毁灭性的感染可能会成为更常见的重建挑战。